Abstract:Abstract Background Drug-induced liver injury (DILI) is a major safety concern characterized by a complex and diverse pathogenesis. In order to identify DILI early in drug development, a better understanding of the injury and models with better predictivity are urgently needed. One approach in this regard are in silico models which aim at predicting the risk of DILI based on the compound structure. However, these models do not yet show sufficient predictive performance or interpretability to be useful for decision making by themselves, the former partially stemming from the underlying problem of labeling the in vivo DILI risk of compounds in a meaningful way for generating machine learning models. Results As part of the Critical Assessment of Massive Data Analysis (CAMDA) “CMap Drug Safety Challenge” 2019 ( http://camda2019.bioinf.jku.at ), chemical structure-based models were generated using the binarized DILIrank annotations. Support Vector Machine (SVM) and Random Forest (RF) classifiers showed comparable performance to previously published models with a mean balanced accuracy over models generated using 5-fold LOCO-CV inside a 10-fold training scheme of 0.759 ± 0.027 when predicting an external test set. In the models which used predicted protein targets as compound descriptors, we identified the most information-rich proteins which agreed with the mechanisms of action and toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs), one of the most important drug classes causing DILI, stress response via TP53 and biotransformation. In addition, we identified multiple proteins involved in xenobiotic metabolism which could be novel DILI-related off-targets, such as CLK1 and DYRK2. Moreover, we derived potential structural alerts for DILI with high precision, including furan and hydrazine derivatives; however, all derived alerts were present in approved drugs and were over specific indicating the need to consider quantitative variables such as dose. Conclusion Using chemical structure-based descriptors such as structural fingerprints and predicted protein targets, DILI prediction models were built with a predictive performance comparable to previous literature. In addition, we derived insights on proteins and pathways statistically (and potentially causally) linked to DILI from these models and inferred new structural alerts related to this adverse endpoint.

Generation of a drug-induced renal injury list to facilitate the development of new approach methodologies for nephrotoxicity

Causal Evaluation of Post-Marketing Drugs for Drug-induced Liver Injury from Electronic Health Records*

Drug-induced kidney injury: challenges and opportunities

The Liver Toxicity Knowledge Base (LKTB) and Drug-Induced Liver Injury (DILI) Classification for Assessment of Human Liver Injury

Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies

An Integrated Approach for Representing Knowledge on the Potential of Drugs to Cause Acute Kidney Injury

Drug-induced kidney injury: analysis of 6 cases

Clinical Characteristics and Outcomes of Drug-Induced Acute Kidney Injury Cases

In silico prediction of drug-induced nephrotoxicity: current progress and pitfalls

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure

Establishment of a Rapid Identification of Adverse Drug Reaction Program in R Language Implementation Based on Monitoring Data

Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use

Drug-induced acute kidney injury: a clinical and pathological analysis

[Promoting Translational Research on Drug-Induced Liver Injury].

Artificial Intelligence and Machine Learning Models for Predicting Drug-Induced Kidney Injury in Small Molecules

Drug-induced liver injury: a comprehensive review

Overview of Research on Drug-induced Liver Injury

Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use

Insights into Mechanisms and Severity of Drug-Induced Liver Injury Via Computational Systems Toxicology Approach.

Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury